nodes	percent_of_prediction	percent_of_DWPC	metapath
Isoniazid—CYP2A6—Ifosfamide—testicular cancer	0.204	0.257	CbGbCtD
Isoniazid—CYP2C8—Ifosfamide—testicular cancer	0.1	0.127	CbGbCtD
Isoniazid—CYP2C19—Ifosfamide—testicular cancer	0.0843	0.106	CbGbCtD
Isoniazid—CYP2C9—Ifosfamide—testicular cancer	0.0701	0.0885	CbGbCtD
Isoniazid—CYP2E1—Etoposide—testicular cancer	0.0643	0.0811	CbGbCtD
Isoniazid—CYP2C8—Etoposide—testicular cancer	0.048	0.0606	CbGbCtD
Isoniazid—CYP3A4—Ifosfamide—testicular cancer	0.0408	0.0514	CbGbCtD
Isoniazid—CYP1A2—Etoposide—testicular cancer	0.0372	0.0469	CbGbCtD
Isoniazid—CYP2C9—Cisplatin—testicular cancer	0.0341	0.043	CbGbCtD
Isoniazid—CYP2D6—Vinblastine—testicular cancer	0.034	0.0429	CbGbCtD
Isoniazid—CYP3A4—Vinblastine—testicular cancer	0.0216	0.0273	CbGbCtD
Isoniazid—CYP2D6—Doxorubicin—testicular cancer	0.0209	0.0264	CbGbCtD
Isoniazid—CYP3A4—Etoposide—testicular cancer	0.0195	0.0246	CbGbCtD
Isoniazid—CYP3A4—Doxorubicin—testicular cancer	0.0133	0.0168	CbGbCtD
Isoniazid—Neurotoxicity—Ifosfamide—testicular cancer	0.00533	0.0257	CcSEcCtD
Isoniazid—Metabolic acidosis—Ifosfamide—testicular cancer	0.00523	0.0252	CcSEcCtD
Isoniazid—Neurotoxicity—Cisplatin—testicular cancer	0.0046	0.0221	CcSEcCtD
Isoniazid—Neurotoxicity—Etoposide—testicular cancer	0.00421	0.0203	CcSEcCtD
Isoniazid—Neuritis—Chlorambucil—testicular cancer	0.00419	0.0201	CcSEcCtD
Isoniazid—Metabolic acidosis—Etoposide—testicular cancer	0.00413	0.0199	CcSEcCtD
Isoniazid—Neuritis—Vinblastine—testicular cancer	0.00384	0.0185	CcSEcCtD
Isoniazid—Eruption—Dactinomycin—testicular cancer	0.00367	0.0177	CcSEcCtD
Isoniazid—Diabetic—Methotrexate—testicular cancer	0.00293	0.0141	CcSEcCtD
Isoniazid—Reaction gastrointestinal—Methotrexate—testicular cancer	0.00293	0.0141	CcSEcCtD
Isoniazid—Optic neuritis—Cisplatin—testicular cancer	0.0029	0.0139	CcSEcCtD
Isoniazid—Lymphadenopathy—Chlorambucil—testicular cancer	0.00266	0.0128	CcSEcCtD
Isoniazid—Optic neuritis—Etoposide—testicular cancer	0.00266	0.0128	CcSEcCtD
Isoniazid—Neurotoxicity—Methotrexate—testicular cancer	0.00252	0.0121	CcSEcCtD
Isoniazid—Neurotoxicity—Epirubicin—testicular cancer	0.00236	0.0114	CcSEcCtD
Isoniazid—Neurotoxicity—Doxorubicin—testicular cancer	0.00218	0.0105	CcSEcCtD
Isoniazid—Vasculitis—Ifosfamide—testicular cancer	0.00212	0.0102	CcSEcCtD
Isoniazid—Aplastic anaemia—Dactinomycin—testicular cancer	0.00212	0.0102	CcSEcCtD
Isoniazid—Liver injury—Cisplatin—testicular cancer	0.00212	0.0102	CcSEcCtD
Isoniazid—Hepatocellular injury—Cisplatin—testicular cancer	0.00178	0.00858	CcSEcCtD
Isoniazid—Hepatic function abnormal—Ifosfamide—testicular cancer	0.00172	0.00826	CcSEcCtD
Isoniazid—Neuropathy peripheral—Chlorambucil—testicular cancer	0.00171	0.00825	CcSEcCtD
Isoniazid—Body temperature increased—Carboplatin—testicular cancer	0.00171	0.00825	CcSEcCtD
Isoniazid—Jaundice—Chlorambucil—testicular cancer	0.0017	0.0082	CcSEcCtD
Isoniazid—Eruption—Methotrexate—testicular cancer	0.00159	0.00765	CcSEcCtD
Isoniazid—Neuropathy peripheral—Vinblastine—testicular cancer	0.00157	0.00756	CcSEcCtD
Isoniazid—Agranulocytosis—Vinblastine—testicular cancer	0.0015	0.0072	CcSEcCtD
Isoniazid—Eruption—Epirubicin—testicular cancer	0.00149	0.00716	CcSEcCtD
Isoniazid—Optic neuritis—Epirubicin—testicular cancer	0.00149	0.00716	CcSEcCtD
Isoniazid—Psychotic disorder—Ifosfamide—testicular cancer	0.00147	0.00705	CcSEcCtD
Isoniazid—Optic neuritis—Doxorubicin—testicular cancer	0.00138	0.00663	CcSEcCtD
Isoniazid—Eruption—Doxorubicin—testicular cancer	0.00138	0.00663	CcSEcCtD
Isoniazid—Neuritis—Epirubicin—testicular cancer	0.00123	0.0059	CcSEcCtD
Isoniazid—Convulsion—Chlorambucil—testicular cancer	0.00118	0.0057	CcSEcCtD
Isoniazid—Agranulocytosis—Dactinomycin—testicular cancer	0.00118	0.00567	CcSEcCtD
Isoniazid—Hyperglycaemia—Ifosfamide—testicular cancer	0.00117	0.00563	CcSEcCtD
Isoniazid—Ill-defined disorder—Vinblastine—testicular cancer	0.00116	0.00559	CcSEcCtD
Isoniazid—Neuritis—Doxorubicin—testicular cancer	0.00113	0.00546	CcSEcCtD
Isoniazid—Neuropathy peripheral—Ifosfamide—testicular cancer	0.00113	0.00546	CcSEcCtD
Isoniazid—Hepatitis—Dactinomycin—testicular cancer	0.00113	0.00545	CcSEcCtD
Isoniazid—Malaise—Vinblastine—testicular cancer	0.00113	0.00543	CcSEcCtD
Isoniazid—Thrombocytopenia—Chlorambucil—testicular cancer	0.00109	0.00525	CcSEcCtD
Isoniazid—Liver injury—Epirubicin—testicular cancer	0.00109	0.00523	CcSEcCtD
Isoniazid—Convulsion—Vinblastine—testicular cancer	0.00109	0.00522	CcSEcCtD
Isoniazid—Agranulocytosis—Ifosfamide—testicular cancer	0.00108	0.00519	CcSEcCtD
Isoniazid—Hyperbilirubinaemia—Methotrexate—testicular cancer	0.00108	0.00518	CcSEcCtD
Isoniazid—Anorexia—Chlorambucil—testicular cancer	0.00106	0.00512	CcSEcCtD
Isoniazid—Discomfort—Vinblastine—testicular cancer	0.00105	0.00507	CcSEcCtD
Isoniazid—Hepatitis—Ifosfamide—testicular cancer	0.00104	0.005	CcSEcCtD
Isoniazid—Hyperbilirubinaemia—Epirubicin—testicular cancer	0.00101	0.00484	CcSEcCtD
Isoniazid—Liver injury—Doxorubicin—testicular cancer	0.00101	0.00484	CcSEcCtD
Isoniazid—Vasculitis—Methotrexate—testicular cancer	0.001	0.00482	CcSEcCtD
Isoniazid—Thrombocytopenia—Vinblastine—testicular cancer	0.001	0.00481	CcSEcCtD
Isoniazid—Dyspepsia—Chlorambucil—testicular cancer	0.000982	0.00472	CcSEcCtD
Isoniazid—Ill-defined disorder—Bleomycin—testicular cancer	0.000981	0.00472	CcSEcCtD
Isoniazid—Neuropathy peripheral—Cisplatin—testicular cancer	0.000978	0.0047	CcSEcCtD
Isoniazid—Anorexia—Vinblastine—testicular cancer	0.000974	0.00469	CcSEcCtD
Isoniazid—Decreased appetite—Chlorambucil—testicular cancer	0.00097	0.00467	CcSEcCtD
Isoniazid—Gastrointestinal disorder—Chlorambucil—testicular cancer	0.000963	0.00463	CcSEcCtD
Isoniazid—Fatigue—Chlorambucil—testicular cancer	0.000962	0.00463	CcSEcCtD
Isoniazid—Malaise—Bleomycin—testicular cancer	0.000954	0.00459	CcSEcCtD
Isoniazid—Hyperbilirubinaemia—Doxorubicin—testicular cancer	0.000932	0.00448	CcSEcCtD
Isoniazid—Feeling abnormal—Chlorambucil—testicular cancer	0.000919	0.00442	CcSEcCtD
Isoniazid—Aplastic anaemia—Methotrexate—testicular cancer	0.000918	0.00442	CcSEcCtD
Isoniazid—Paraesthesia—Vinblastine—testicular cancer	0.000918	0.00442	CcSEcCtD
Isoniazid—Hepatocellular injury—Epirubicin—testicular cancer	0.000916	0.00441	CcSEcCtD
Isoniazid—Ill-defined disorder—Dactinomycin—testicular cancer	0.000915	0.0044	CcSEcCtD
Isoniazid—Neuropathy peripheral—Etoposide—testicular cancer	0.000896	0.00431	CcSEcCtD
Isoniazid—Jaundice—Etoposide—testicular cancer	0.000891	0.00428	CcSEcCtD
Isoniazid—Discomfort—Bleomycin—testicular cancer	0.00089	0.00428	CcSEcCtD
Isoniazid—Malaise—Dactinomycin—testicular cancer	0.00089	0.00428	CcSEcCtD
Isoniazid—Decreased appetite—Vinblastine—testicular cancer	0.000889	0.00427	CcSEcCtD
Isoniazid—Body temperature increased—Chlorambucil—testicular cancer	0.000882	0.00424	CcSEcCtD
Isoniazid—Gynaecomastia—Methotrexate—testicular cancer	0.000875	0.00421	CcSEcCtD
Isoniazid—Aplastic anaemia—Epirubicin—testicular cancer	0.00086	0.00414	CcSEcCtD
Isoniazid—Agranulocytosis—Etoposide—testicular cancer	0.000853	0.0041	CcSEcCtD
Isoniazid—Hepatocellular injury—Doxorubicin—testicular cancer	0.000847	0.00408	CcSEcCtD
Isoniazid—Thrombocytopenia—Bleomycin—testicular cancer	0.000845	0.00407	CcSEcCtD
Isoniazid—Feeling abnormal—Vinblastine—testicular cancer	0.000842	0.00405	CcSEcCtD
Isoniazid—Ill-defined disorder—Ifosfamide—testicular cancer	0.000839	0.00404	CcSEcCtD
Isoniazid—Lymphadenopathy—Methotrexate—testicular cancer	0.000832	0.004	CcSEcCtD
Isoniazid—Discomfort—Dactinomycin—testicular cancer	0.00083	0.00399	CcSEcCtD
Isoniazid—Anorexia—Bleomycin—testicular cancer	0.000823	0.00396	CcSEcCtD
Isoniazid—Hypersensitivity—Chlorambucil—testicular cancer	0.000822	0.00395	CcSEcCtD
Isoniazid—Diabetes mellitus—Methotrexate—testicular cancer	0.000816	0.00393	CcSEcCtD
Isoniazid—Malaise—Ifosfamide—testicular cancer	0.000815	0.00392	CcSEcCtD
Isoniazid—Asthenia—Chlorambucil—testicular cancer	0.0008	0.00385	CcSEcCtD
Isoniazid—Aplastic anaemia—Doxorubicin—testicular cancer	0.000795	0.00383	CcSEcCtD
Isoniazid—Thrombocytopenia—Dactinomycin—testicular cancer	0.000788	0.00379	CcSEcCtD
Isoniazid—Convulsion—Ifosfamide—testicular cancer	0.000783	0.00377	CcSEcCtD
Isoniazid—Lymphadenopathy—Epirubicin—testicular cancer	0.000779	0.00375	CcSEcCtD
Isoniazid—Paraesthesia—Bleomycin—testicular cancer	0.000775	0.00373	CcSEcCtD
Isoniazid—Anorexia—Dactinomycin—testicular cancer	0.000767	0.00369	CcSEcCtD
Isoniazid—Diabetes mellitus—Epirubicin—testicular cancer	0.000764	0.00368	CcSEcCtD
Isoniazid—Hepatic function abnormal—Epirubicin—testicular cancer	0.00076	0.00366	CcSEcCtD
Isoniazid—Discomfort—Ifosfamide—testicular cancer	0.00076	0.00366	CcSEcCtD
Isoniazid—Hypersensitivity—Vinblastine—testicular cancer	0.000753	0.00362	CcSEcCtD
Isoniazid—Decreased appetite—Bleomycin—testicular cancer	0.00075	0.00361	CcSEcCtD
Isoniazid—Asthenia—Vinblastine—testicular cancer	0.000733	0.00353	CcSEcCtD
Isoniazid—Ill-defined disorder—Cisplatin—testicular cancer	0.000723	0.00348	CcSEcCtD
Isoniazid—Thrombocytopenia—Ifosfamide—testicular cancer	0.000722	0.00348	CcSEcCtD
Isoniazid—Lymphadenopathy—Doxorubicin—testicular cancer	0.000721	0.00347	CcSEcCtD
Isoniazid—Feeling abnormal—Bleomycin—testicular cancer	0.000711	0.00342	CcSEcCtD
Isoniazid—Vomiting—Chlorambucil—testicular cancer	0.000709	0.00341	CcSEcCtD
Isoniazid—Diabetes mellitus—Doxorubicin—testicular cancer	0.000707	0.0034	CcSEcCtD
Isoniazid—Hepatic function abnormal—Doxorubicin—testicular cancer	0.000704	0.00339	CcSEcCtD
Isoniazid—Anorexia—Ifosfamide—testicular cancer	0.000703	0.00338	CcSEcCtD
Isoniazid—Malaise—Cisplatin—testicular cancer	0.000703	0.00338	CcSEcCtD
Isoniazid—Decreased appetite—Dactinomycin—testicular cancer	0.0007	0.00337	CcSEcCtD
Isoniazid—Fatigue—Dactinomycin—testicular cancer	0.000694	0.00334	CcSEcCtD
Isoniazid—Body temperature increased—Bleomycin—testicular cancer	0.000682	0.00328	CcSEcCtD
Isoniazid—Convulsion—Cisplatin—testicular cancer	0.000675	0.00325	CcSEcCtD
Isoniazid—Feeling abnormal—Dactinomycin—testicular cancer	0.000663	0.00319	CcSEcCtD
Isoniazid—Nausea—Chlorambucil—testicular cancer	0.000663	0.00319	CcSEcCtD
Isoniazid—Paraesthesia—Ifosfamide—testicular cancer	0.000662	0.00319	CcSEcCtD
Isoniazid—Ill-defined disorder—Etoposide—testicular cancer	0.000662	0.00319	CcSEcCtD
Isoniazid—Discomfort—Cisplatin—testicular cancer	0.000656	0.00315	CcSEcCtD
Isoniazid—Vomiting—Vinblastine—testicular cancer	0.00065	0.00313	CcSEcCtD
Isoniazid—Malaise—Etoposide—testicular cancer	0.000644	0.0031	CcSEcCtD
Isoniazid—Decreased appetite—Ifosfamide—testicular cancer	0.000641	0.00309	CcSEcCtD
Isoniazid—Gastrointestinal disorder—Ifosfamide—testicular cancer	0.000637	0.00306	CcSEcCtD
Isoniazid—Body temperature increased—Dactinomycin—testicular cancer	0.000636	0.00306	CcSEcCtD
Isoniazid—Fatigue—Ifosfamide—testicular cancer	0.000636	0.00306	CcSEcCtD
Isoniazid—Hypersensitivity—Bleomycin—testicular cancer	0.000636	0.00306	CcSEcCtD
Isoniazid—Thrombocytopenia—Cisplatin—testicular cancer	0.000623	0.003	CcSEcCtD
Isoniazid—Asthenia—Bleomycin—testicular cancer	0.000619	0.00298	CcSEcCtD
Isoniazid—Convulsion—Etoposide—testicular cancer	0.000619	0.00298	CcSEcCtD
Isoniazid—Feeling abnormal—Ifosfamide—testicular cancer	0.000608	0.00293	CcSEcCtD
Isoniazid—Eosinophilia—Methotrexate—testicular cancer	0.000608	0.00292	CcSEcCtD
Isoniazid—Nausea—Vinblastine—testicular cancer	0.000607	0.00292	CcSEcCtD
Isoniazid—Anorexia—Cisplatin—testicular cancer	0.000606	0.00292	CcSEcCtD
Isoniazid—Discomfort—Etoposide—testicular cancer	0.000601	0.00289	CcSEcCtD
Isoniazid—Hypersensitivity—Dactinomycin—testicular cancer	0.000593	0.00285	CcSEcCtD
Isoniazid—Body temperature increased—Ifosfamide—testicular cancer	0.000583	0.00281	CcSEcCtD
Isoniazid—Asthenia—Dactinomycin—testicular cancer	0.000578	0.00278	CcSEcCtD
Isoniazid—Paraesthesia—Cisplatin—testicular cancer	0.000571	0.00275	CcSEcCtD
Isoniazid—Thrombocytopenia—Etoposide—testicular cancer	0.000571	0.00274	CcSEcCtD
Isoniazid—Eosinophilia—Epirubicin—testicular cancer	0.000569	0.00274	CcSEcCtD
Isoniazid—Anorexia—Etoposide—testicular cancer	0.000555	0.00267	CcSEcCtD
Isoniazid—Decreased appetite—Cisplatin—testicular cancer	0.000553	0.00266	CcSEcCtD
Isoniazid—Gastrointestinal disorder—Cisplatin—testicular cancer	0.000549	0.00264	CcSEcCtD
Isoniazid—Vomiting—Bleomycin—testicular cancer	0.000549	0.00264	CcSEcCtD
Isoniazid—Rash—Bleomycin—testicular cancer	0.000544	0.00262	CcSEcCtD
Isoniazid—Hypersensitivity—Ifosfamide—testicular cancer	0.000544	0.00262	CcSEcCtD
Isoniazid—Asthenia—Ifosfamide—testicular cancer	0.000529	0.00255	CcSEcCtD
Isoniazid—Eosinophilia—Doxorubicin—testicular cancer	0.000526	0.00253	CcSEcCtD
Isoniazid—Feeling abnormal—Cisplatin—testicular cancer	0.000524	0.00252	CcSEcCtD
Isoniazid—Paraesthesia—Etoposide—testicular cancer	0.000523	0.00252	CcSEcCtD
Isoniazid—Hyperglycaemia—Epirubicin—testicular cancer	0.000518	0.00249	CcSEcCtD
Isoniazid—Nausea—Bleomycin—testicular cancer	0.000513	0.00247	CcSEcCtD
Isoniazid—Vomiting—Dactinomycin—testicular cancer	0.000512	0.00246	CcSEcCtD
Isoniazid—Agranulocytosis—Methotrexate—testicular cancer	0.000511	0.00246	CcSEcCtD
Isoniazid—Rash—Dactinomycin—testicular cancer	0.000508	0.00244	CcSEcCtD
Isoniazid—Decreased appetite—Etoposide—testicular cancer	0.000507	0.00244	CcSEcCtD
Isoniazid—Gastrointestinal disorder—Etoposide—testicular cancer	0.000503	0.00242	CcSEcCtD
Isoniazid—Body temperature increased—Cisplatin—testicular cancer	0.000503	0.00242	CcSEcCtD
Isoniazid—Fatigue—Etoposide—testicular cancer	0.000502	0.00242	CcSEcCtD
Isoniazid—Neuropathy peripheral—Epirubicin—testicular cancer	0.000502	0.00242	CcSEcCtD
Isoniazid—Jaundice—Epirubicin—testicular cancer	0.000499	0.0024	CcSEcCtD
Isoniazid—Hepatitis—Methotrexate—testicular cancer	0.000491	0.00236	CcSEcCtD
Isoniazid—Feeling abnormal—Etoposide—testicular cancer	0.00048	0.00231	CcSEcCtD
Isoniazid—Hyperglycaemia—Doxorubicin—testicular cancer	0.000479	0.00231	CcSEcCtD
Isoniazid—Nausea—Dactinomycin—testicular cancer	0.000478	0.0023	CcSEcCtD
Isoniazid—Agranulocytosis—Epirubicin—testicular cancer	0.000478	0.0023	CcSEcCtD
Isoniazid—Vomiting—Ifosfamide—testicular cancer	0.000469	0.00226	CcSEcCtD
Isoniazid—Hypersensitivity—Cisplatin—testicular cancer	0.000469	0.00225	CcSEcCtD
Isoniazid—Rash—Ifosfamide—testicular cancer	0.000465	0.00224	CcSEcCtD
Isoniazid—Neuropathy peripheral—Doxorubicin—testicular cancer	0.000464	0.00223	CcSEcCtD
Isoniazid—Jaundice—Doxorubicin—testicular cancer	0.000462	0.00222	CcSEcCtD
Isoniazid—Body temperature increased—Etoposide—testicular cancer	0.000461	0.00222	CcSEcCtD
Isoniazid—Hepatitis—Epirubicin—testicular cancer	0.00046	0.00221	CcSEcCtD
Isoniazid—Asthenia—Cisplatin—testicular cancer	0.000456	0.0022	CcSEcCtD
Isoniazid—Agranulocytosis—Doxorubicin—testicular cancer	0.000442	0.00213	CcSEcCtD
Isoniazid—Nausea—Ifosfamide—testicular cancer	0.000438	0.00211	CcSEcCtD
Isoniazid—Hypersensitivity—Etoposide—testicular cancer	0.000429	0.00207	CcSEcCtD
Isoniazid—Hepatitis—Doxorubicin—testicular cancer	0.000425	0.00205	CcSEcCtD
Isoniazid—Asthenia—Etoposide—testicular cancer	0.000418	0.00201	CcSEcCtD
Isoniazid—Vomiting—Cisplatin—testicular cancer	0.000404	0.00195	CcSEcCtD
Isoniazid—Rash—Cisplatin—testicular cancer	0.000401	0.00193	CcSEcCtD
Isoniazid—Ill-defined disorder—Methotrexate—testicular cancer	0.000397	0.00191	CcSEcCtD
Isoniazid—Malaise—Methotrexate—testicular cancer	0.000386	0.00186	CcSEcCtD
Isoniazid—Nausea—Cisplatin—testicular cancer	0.000378	0.00182	CcSEcCtD
Isoniazid—Ill-defined disorder—Epirubicin—testicular cancer	0.000371	0.00179	CcSEcCtD
Isoniazid—Convulsion—Methotrexate—testicular cancer	0.000371	0.00178	CcSEcCtD
Isoniazid—Vomiting—Etoposide—testicular cancer	0.00037	0.00178	CcSEcCtD
Isoniazid—Rash—Etoposide—testicular cancer	0.000367	0.00177	CcSEcCtD
Isoniazid—Malaise—Epirubicin—testicular cancer	0.000361	0.00174	CcSEcCtD
Isoniazid—Discomfort—Methotrexate—testicular cancer	0.00036	0.00173	CcSEcCtD
Isoniazid—Convulsion—Epirubicin—testicular cancer	0.000347	0.00167	CcSEcCtD
Isoniazid—Nausea—Etoposide—testicular cancer	0.000346	0.00167	CcSEcCtD
Isoniazid—Ill-defined disorder—Doxorubicin—testicular cancer	0.000344	0.00165	CcSEcCtD
Isoniazid—Thrombocytopenia—Methotrexate—testicular cancer	0.000342	0.00164	CcSEcCtD
Isoniazid—Discomfort—Epirubicin—testicular cancer	0.000337	0.00162	CcSEcCtD
Isoniazid—Malaise—Doxorubicin—testicular cancer	0.000334	0.00161	CcSEcCtD
Isoniazid—Anorexia—Methotrexate—testicular cancer	0.000333	0.0016	CcSEcCtD
Isoniazid—Convulsion—Doxorubicin—testicular cancer	0.000321	0.00154	CcSEcCtD
Isoniazid—Thrombocytopenia—Epirubicin—testicular cancer	0.00032	0.00154	CcSEcCtD
Isoniazid—Paraesthesia—Methotrexate—testicular cancer	0.000313	0.00151	CcSEcCtD
Isoniazid—Discomfort—Doxorubicin—testicular cancer	0.000311	0.0015	CcSEcCtD
Isoniazid—Anorexia—Epirubicin—testicular cancer	0.000311	0.0015	CcSEcCtD
Isoniazid—Dyspepsia—Methotrexate—testicular cancer	0.000307	0.00148	CcSEcCtD
Isoniazid—Decreased appetite—Methotrexate—testicular cancer	0.000303	0.00146	CcSEcCtD
Isoniazid—Gastrointestinal disorder—Methotrexate—testicular cancer	0.000301	0.00145	CcSEcCtD
Isoniazid—Fatigue—Methotrexate—testicular cancer	0.000301	0.00145	CcSEcCtD
Isoniazid—Thrombocytopenia—Doxorubicin—testicular cancer	0.000296	0.00142	CcSEcCtD
Isoniazid—Paraesthesia—Epirubicin—testicular cancer	0.000293	0.00141	CcSEcCtD
Isoniazid—Anorexia—Doxorubicin—testicular cancer	0.000288	0.00139	CcSEcCtD
Isoniazid—Feeling abnormal—Methotrexate—testicular cancer	0.000288	0.00138	CcSEcCtD
Isoniazid—Dyspepsia—Epirubicin—testicular cancer	0.000288	0.00138	CcSEcCtD
Isoniazid—Decreased appetite—Epirubicin—testicular cancer	0.000284	0.00137	CcSEcCtD
Isoniazid—Gastrointestinal disorder—Epirubicin—testicular cancer	0.000282	0.00136	CcSEcCtD
Isoniazid—Fatigue—Epirubicin—testicular cancer	0.000282	0.00135	CcSEcCtD
Isoniazid—Body temperature increased—Methotrexate—testicular cancer	0.000276	0.00133	CcSEcCtD
Isoniazid—Paraesthesia—Doxorubicin—testicular cancer	0.000271	0.00131	CcSEcCtD
Isoniazid—Feeling abnormal—Epirubicin—testicular cancer	0.000269	0.0013	CcSEcCtD
Isoniazid—Dyspepsia—Doxorubicin—testicular cancer	0.000266	0.00128	CcSEcCtD
Isoniazid—Decreased appetite—Doxorubicin—testicular cancer	0.000263	0.00126	CcSEcCtD
Isoniazid—Gastrointestinal disorder—Doxorubicin—testicular cancer	0.000261	0.00126	CcSEcCtD
Isoniazid—Fatigue—Doxorubicin—testicular cancer	0.000261	0.00125	CcSEcCtD
Isoniazid—Body temperature increased—Epirubicin—testicular cancer	0.000258	0.00124	CcSEcCtD
Isoniazid—Hypersensitivity—Methotrexate—testicular cancer	0.000257	0.00124	CcSEcCtD
Isoniazid—Asthenia—Methotrexate—testicular cancer	0.00025	0.0012	CcSEcCtD
Isoniazid—Feeling abnormal—Doxorubicin—testicular cancer	0.000249	0.0012	CcSEcCtD
Isoniazid—Hypersensitivity—Epirubicin—testicular cancer	0.000241	0.00116	CcSEcCtD
Isoniazid—Body temperature increased—Doxorubicin—testicular cancer	0.000239	0.00115	CcSEcCtD
Isoniazid—Asthenia—Epirubicin—testicular cancer	0.000234	0.00113	CcSEcCtD
Isoniazid—Hypersensitivity—Doxorubicin—testicular cancer	0.000223	0.00107	CcSEcCtD
Isoniazid—Vomiting—Methotrexate—testicular cancer	0.000222	0.00107	CcSEcCtD
Isoniazid—Rash—Methotrexate—testicular cancer	0.00022	0.00106	CcSEcCtD
Isoniazid—Asthenia—Doxorubicin—testicular cancer	0.000217	0.00104	CcSEcCtD
Isoniazid—Vomiting—Epirubicin—testicular cancer	0.000208	0.000999	CcSEcCtD
Isoniazid—Nausea—Methotrexate—testicular cancer	0.000207	0.000997	CcSEcCtD
Isoniazid—Rash—Epirubicin—testicular cancer	0.000206	0.000991	CcSEcCtD
Isoniazid—Nausea—Epirubicin—testicular cancer	0.000194	0.000933	CcSEcCtD
Isoniazid—Vomiting—Doxorubicin—testicular cancer	0.000192	0.000925	CcSEcCtD
Isoniazid—Rash—Doxorubicin—testicular cancer	0.000191	0.000917	CcSEcCtD
Isoniazid—Nausea—Doxorubicin—testicular cancer	0.00018	0.000864	CcSEcCtD
